{
    "medicine_id": "35e60cd7e75da511f8fdb1a9df2b0feb7f17a09f",
    "platform_id": "DB08808",
    "metadata": {
        "name": "Deca Durabolin Inj 100mg ml 50 mg Solution",
        "composition": "50 mg Bupranolol",
        "clinical_particulars": {
            "therapeutic_indications": "Used to manage hypertension and tachycardia Also used to treat glaucoma",
            "contraindications": {
                "disease": "Symptoms of overdose include bradycardia cardiac failure hypotension and brochospasm",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Bupranolol is a competitive nonselective beta blocker similar to propanolol without intrinsic sympathomimetic activity",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09063",
                        "description": "Bupranolol may increase the bradycardic activities of Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "Bupranolol may increase the bradycardic activities of Ivabradine"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Ruxolitinib may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "Alfuzosin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01143",
                        "description": "Bupranolol may increase the hypotensive activities of Amifostine"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Dexmethylphenidate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "Bupranolol may increase the hypotensive activities of Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "Bupranolol may increase the hypotensive activities of Rituximab"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "Zolmitriptan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "Doxapram may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "Phenmetrazine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Naratriptan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Frovatriptan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "Dutasteride may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "Finasteride may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "Yohimbine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "Epicaptopril may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "1 benzylimidazole may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Amineptine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Flibanserin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Naluzotan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "Nitrous oxide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Cinitapride may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "Tyramine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "Ifenprodil may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Moxisylyte may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Tianeptine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Oxaprotiline may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "Atipamezole may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Piclozotan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "Siponimod may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "Idazoxan may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "Tramazoline may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Amitriptylinoxide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Dibenzepin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Quinupramine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "Trichloroethylene may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "Fenozolone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Melitracen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Lofepramine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "Xenon may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Iprindole may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "Buflomedil may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Diethyl ether may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Imipramine oxide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "Mefenorex may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "5 methoxy N N dimethyltryptamine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "Quinoline Yellow WS may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Solriamfetol may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "Sufentanil may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "Remifentanil may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "Halothane may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "Selpercatinib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The serum concentration of Bupivacaine can be increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "Dipyridamole may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Disopyramide may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Dronedarone may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Bupranolol may increase the bradycardic activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Floctafenine"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "The serum concentration of Mepivacaine can be increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06709",
                        "description": "Bupranolol may increase the bronchoconstrictory activities of Methacholine"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The therapeutic efficacy of Midodrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of adverse effects can be increased when Propafenone is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "Regorafenib may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Deserpidine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "Bupranolol may increase the bradycardic activities of Rivastigmine"
                    },
                    {
                        "drugbank-id": "DB09282",
                        "description": "Molsidomine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11564",
                        "description": "Bupranolol may increase the hypoglycemic activities of Insulin argine"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Remikiren may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Guanadrel may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00287",
                        "description": "Travoprost may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Bosentan may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Candoxatril may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Metyrosine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Cryptenamine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00869",
                        "description": "Dorzolamide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00905",
                        "description": "Bimatoprost may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Pentolinium may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Trimethaphan may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Debrisoquine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Sitaxentan may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Ambrisentan may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Diethylnorspermine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Pinacidil may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06826",
                        "description": "Unoprostone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Ferulic acid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Bupranolol may increase the hypotensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Bupranolol may increase the hypotensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Bupranolol may increase the hypotensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Bupranolol may increase the hypotensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Bupranolol may increase the hypotensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Bupranolol may increase the hypotensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Bupranolol may increase the hypotensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Bupranolol may increase the hypotensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Bupranolol may increase the hypotensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Bupranolol may increase the hypotensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Bupranolol may increase the hypotensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Bupranolol may increase the hypotensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Bupranolol may increase the hypotensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Bupranolol may increase the hypotensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Bupranolol may increase the hypotensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Bupranolol may increase the hypotensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Bupranolol may increase the hypotensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Bupranolol may increase the hypotensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Bupranolol may increase the hypotensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Bupranolol may increase the hypotensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Bupranolol may increase the hypotensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Bupranolol may increase the hypotensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Minoxidil may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Nitroglycerin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Hydralazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Riociguat may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Ramipril may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Perindopril may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Bupranolol may increase the hypotensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Cevimeline"
                    },
                    {
                        "drugbank-id": "DB00411",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Carbamoylcholine"
                    },
                    {
                        "drugbank-id": "DB01019",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Bethanechol"
                    },
                    {
                        "drugbank-id": "DB01085",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Pilocarpine"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Varenicline"
                    },
                    {
                        "drugbank-id": "DB03128",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Acetylcholine"
                    },
                    {
                        "drugbank-id": "DB04365",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Arecoline"
                    },
                    {
                        "drugbank-id": "DB05137",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Lobeline"
                    },
                    {
                        "drugbank-id": "DB05152",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with NGX267"
                    },
                    {
                        "drugbank-id": "DB05708",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with GTS 21"
                    },
                    {
                        "drugbank-id": "DB07720",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Epibatidine"
                    },
                    {
                        "drugbank-id": "DB15357",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Xanomeline"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "Bupranolol may increase the bradycardic activities of Ouabain"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "Bupranolol may increase the bradycardic activities of Oleandrin"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "Bupranolol may increase the bradycardic activities of Proscillaridin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "Bupranolol may increase the bradycardic activities of Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "Bupranolol may increase the bradycardic activities of Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "Bupranolol may increase the bradycardic activities of Peruvoside"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The serum concentration of Lidocaine can be increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "Taxifolin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "Licofelone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Tepoxalin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "Polmacoxib may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "Ebselen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "Flurbiprofen axetil may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Loxoprofen may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "Sildenafil may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tadalafil may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "Ibudilast may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "Avanafil may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "Udenafil may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "Mirodenafil may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "Fostamatinib may increase the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Bupranolol may increase the vasoconstricting activities of Methysergide"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Bupranolol may increase the vasoconstricting activities of Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Bupranolol may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Bupranolol may increase the vasoconstricting activities of Methylergometrine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Bupranolol may increase the vasoconstricting activities of Lisuride"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Bupranolol may increase the vasoconstricting activities of Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Bupranolol may increase the vasoconstricting activities of Nicergoline"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Bupranolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Bupranolol may increase the vasoconstricting activities of Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Bupranolol may increase the vasoconstricting activities of Dihydroergocornine"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Bupranolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Bupranolol may increase the vasoconstricting activities of Dihydroergocryptine"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Bupranolol may increase the vasoconstricting activities of Terguride"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Bupranolol may increase the vasoconstricting activities of Metergoline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Caffeine"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Dyphylline"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Aminophylline"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Oxtriphylline"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Theobromine"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Fenethylline"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 8 azaguanine"
                    },
                    {
                        "drugbank-id": "DB01978",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 7 9 Dimethylguanine"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Xanthine"
                    },
                    {
                        "drugbank-id": "DB02245",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 7 Deazaguanine"
                    },
                    {
                        "drugbank-id": "DB02377",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Guanine"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 9 Methylguanine"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Peldesine"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Hypoxanthine"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 9 Deazaguanine"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Propentofylline"
                    },
                    {
                        "drugbank-id": "DB06575",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Valomaciclovir"
                    },
                    {
                        "drugbank-id": "DB07954",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 3 isobutyl 1 methyl 7H xanthine"
                    },
                    {
                        "drugbank-id": "DB08844",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Uric acid"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 6 O benzylguanine"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Lisofylline"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Lobucavir"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Cafedrine"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Theodrenaline"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Bamifylline"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Proxyphylline"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Acefylline"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Etamiphylline"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Pentifylline"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Bufylline"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Bromotheophylline"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Furafylline"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with 8 chlorotheophylline"
                    },
                    {
                        "drugbank-id": "DB15122",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with PCS 499"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Carteolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Metipranolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Dexpropranolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Digitoxin"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Cymarin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Glimepiride"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "Tocainide may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Tropisetron"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Spiradoline"
                    },
                    {
                        "drugbank-id": "DB13635",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Tiracizine"
                    },
                    {
                        "drugbank-id": "DB13645",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Ethacizine"
                    },
                    {
                        "drugbank-id": "DB13718",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Hydroquinine"
                    },
                    {
                        "drugbank-id": "DB13746",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Bioallethrin"
                    },
                    {
                        "drugbank-id": "DB13863",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Fosfructose"
                    },
                    {
                        "drugbank-id": "DB15300",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Hydroquinidine"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "SOR C13 may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Adenosine"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Azimilide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Tedisamil"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Simendan"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Lorcainide"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Losartan may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Practolol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Tertatolol"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "Encainide may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "Cariporide may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Lorajmine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Bretylium may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "Sparteine may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "Mexiletine may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "Aprindine may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Sotalol"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Procainamide"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Flecainide"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "Levomenthol may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of bradycardia can be increased when Isradipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of bradycardia can be increased when Trimethadione is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of bradycardia can be increased when Amlodipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The risk or severity of bradycardia can be increased when Nisoldipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of bradycardia can be increased when Lamotrigine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of bradycardia can be increased when Ethosuximide is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of bradycardia can be increased when Zonisamide is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of bradycardia can be increased when Felodipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of bradycardia can be increased when Nitrendipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of bradycardia can be increased when Cyclandelate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of bradycardia can be increased when Flunarizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The risk or severity of bradycardia can be increased when Clevidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of bradycardia can be increased when Methsuximide is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of bradycardia can be increased when Seletracetam is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of bradycardia can be increased when Ziconotide is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of bradycardia can be increased when Dotarizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bradycardia can be increased when Tranilast is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The risk or severity of bradycardia can be increased when Fasudil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of bradycardia can be increased when Agmatine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of bradycardia can be increased when Trimebutine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of bradycardia can be increased when Pinaverium is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of bradycardia can be increased when Aranidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of bradycardia can be increased when Azelnidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of bradycardia can be increased when Cilnidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of bradycardia can be increased when Darodipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of bradycardia can be increased when Efonidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of bradycardia can be increased when Lacidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of bradycardia can be increased when Niludipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of bradycardia can be increased when Carboxyamidotriazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bradycardia can be increased when Naftopidil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of bradycardia can be increased when Tetrahydropalmatine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of bradycardia can be increased when Vinpocetine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of bradycardia can be increased when Gallopamil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of bradycardia can be increased when Bencyclane is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of bradycardia can be increased when Lidoflazine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of bradycardia can be increased when Caroverine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of bradycardia can be increased when WIN 55212 2 is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The risk or severity of bradycardia can be increased when Fish oil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of bradycardia can be increased when Emopamil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of bradycardia can be increased when Lomerizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of bradycardia can be increased when Tetrandrine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of bradycardia can be increased when Dexniguldipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of bradycardia can be increased when Bupranolol is combined with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of bradycardia can be increased when Lercanidipine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Labetalol"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Risperidone"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Silodosin"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Indoramin"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB12230",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Bunazosin"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "Bupranolol may increase the orthostatic hypotensive activities of Bucindolol"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Treprostinil may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "Iloprost may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14337",
                        "description": "Salvia miltiorrhiza root may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "Pegvisomant may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "Tacrine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Profenamine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Gallamine triethiodide may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Cisplatin may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "Cinchocaine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "Pyridostigmine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "Nizatidine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "Galantamine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "Isoflurophate may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "Diethylcarbamazine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "Donepezil may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "Mechlorethamine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "Hexafluronium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "Demecarium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "Physostigmine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "Ambenonium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Pancuronium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Pipecuronium may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "Ginkgo biloba may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "Neostigmine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "1 10 Phenanthroline may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "Thiotepa may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "Huperzine A may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "Phenserine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "Regramostim may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "Aprotinin may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "Glycine betaine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "Capsaicin may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "Coumaphos may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "Dichlorvos may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "Fenthion may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "Metrifonate may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "Acotiamide may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "Methanesulfonyl Fluoride may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "Paraoxon may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "Tyrothricin may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "Ipidacrine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "Distigmine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "Tretamine may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "Posiphen may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "Methylphosphinic Acid may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Isoetharine"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Bitolterol"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Formoterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Salbutamol"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Bambuterol"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Protokylol"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Doxofylline"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "Bupranolol may decrease the bronchodilatory activities of PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Abediterol"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The serum concentration of Bupranolol can be decreased when it is combined with Butabarbital"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "Alfentanil may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Fentanyl may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04897",
                        "description": "Lucinactant may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "Lacosamide may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06415",
                        "description": "Calfactant may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06761",
                        "description": "Beractant may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "Lanreotide may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Bupranolol may increase the bradycardic activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB09113",
                        "description": "Bupranolol may increase the bradycardic activities of Poractant alfa"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Clozapine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Lumefantrine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Imipramine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be decreased when Amodiaquine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The risk or severity of hyperkalemia can be increased when Valsartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of hyperkalemia can be increased when Triamterene is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of hyperkalemia can be increased when Benazepril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of hyperkalemia can be increased when Enalapril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The risk or severity of hyperkalemia can be increased when Amiloride is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of hyperkalemia can be increased when Mannitol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The risk or severity of hyperkalemia can be increased when Candesartan cilexetil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of hyperkalemia can be increased when Quinapril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of hyperkalemia can be increased when Pindolol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of hyperkalemia can be increased when Heparin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of hyperkalemia can be increased when Captopril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of hyperkalemia can be increased when Cilazapril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01342",
                        "description": "The risk or severity of hyperkalemia can be increased when Forasartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "The risk or severity of hyperkalemia can be increased when Saprisartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of hyperkalemia can be increased when Spirapril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01349",
                        "description": "The risk or severity of hyperkalemia can be increased when Tasosartan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of hyperkalemia can be increased when Penbutolol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The risk or severity of hyperkalemia can be increased when Drospirenone is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB02968",
                        "description": "The risk or severity of hyperkalemia can be increased when Penicillin G Acyl Serine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The risk or severity of hyperkalemia can be increased when Bufuralol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hyperkalemia can be increased when Saralasin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "The risk or severity of hyperkalemia can be increased when Ammonium chloride is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The risk or severity of hyperkalemia can be increased when Bopindolol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Azilsartan medoxomil"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Temocapril"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Canrenoic acid"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Arotinolol"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB09261",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Certoparin"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Fimasartan"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Levobetaxolol"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB12097",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Mannitol busulfan"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Canrenone"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Delapril"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Mepindolol"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Epanolol"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of hyperkalemia can be increased when Bupranolol is combined with Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB10349",
                        "description": "The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10351",
                        "description": "The risk of a hypersensitivity reaction to Cynodon dactylon pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10353",
                        "description": "The risk of a hypersensitivity reaction to Poa annua pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10365",
                        "description": "The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10366",
                        "description": "The risk of a hypersensitivity reaction to Poa pratensis pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10370",
                        "description": "The risk of a hypersensitivity reaction to Festuca pratensis pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10379",
                        "description": "The risk of a hypersensitivity reaction to Dactylis glomerata pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10389",
                        "description": "The risk of a hypersensitivity reaction to Lolium perenne pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10394",
                        "description": "The risk of a hypersensitivity reaction to Phleum pratense pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10395",
                        "description": "The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10403",
                        "description": "The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10404",
                        "description": "The risk of a hypersensitivity reaction to Anthoxanthum odoratum pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10489",
                        "description": "The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10494",
                        "description": "The risk of a hypersensitivity reaction to Distichlis spicata pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10713",
                        "description": "The risk of a hypersensitivity reaction to Poa compressa pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10714",
                        "description": "The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10715",
                        "description": "The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10716",
                        "description": "The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10717",
                        "description": "The risk of a hypersensitivity reaction to Secale cereale pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10719",
                        "description": "The risk of a hypersensitivity reaction to Pascopyrum smithii pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10836",
                        "description": "The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10879",
                        "description": "The risk of a hypersensitivity reaction to Arrhenatherum elatius pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10949",
                        "description": "The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10962",
                        "description": "The risk of a hypersensitivity reaction to Agrostis stolonifera pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10963",
                        "description": "The risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10964",
                        "description": "The risk of a hypersensitivity reaction to Lolium perenne subsp multiflorum pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB10966",
                        "description": "The risk of a hypersensitivity reaction to Sorghum bicolor subsp drummondii pollen is increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Bupranolol can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Bupranolol can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The metabolism of Bupranolol can be increased when combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Bupranolol can be increased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB15213",
                        "description": "The metabolism of Bupranolol can be increased when combined with 25 desacetylrifapentine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Bupranolol may increase the antihypertensive activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Bupranolol may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The therapeutic efficacy of Bethanidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The therapeutic efficacy of Etomidate can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The therapeutic efficacy of Metaraminol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The therapeutic efficacy of Tizanidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The therapeutic efficacy of Methoxamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The therapeutic efficacy of Methyldopa can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The therapeutic efficacy of Pergolide can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The therapeutic efficacy of Ergometrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The therapeutic efficacy of Ephedrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The therapeutic efficacy of 4 Methoxyamphetamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01537",
                        "description": "The therapeutic efficacy of 4 Bromo 2 5 dimethoxyphenethylamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The therapeutic efficacy of Phendimetrazine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Lofexidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The therapeutic efficacy of Amibegron can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The therapeutic efficacy of Solabegron can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The therapeutic efficacy of Isometheptene can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The therapeutic efficacy of Naphazoline can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The therapeutic efficacy of Adrafinil can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The therapeutic efficacy of Etilefrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The therapeutic efficacy of Cirazoline can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The therapeutic efficacy of Synephrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The therapeutic efficacy of Moxonidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The therapeutic efficacy of DL Methylephedrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The therapeutic efficacy of Amitraz can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The therapeutic efficacy of Medetomidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The therapeutic efficacy of Xylazine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The therapeutic efficacy of Ractopamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The therapeutic efficacy of Romifidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The therapeutic efficacy of Detomidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The therapeutic efficacy of Dopexamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The therapeutic efficacy of Higenamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The therapeutic efficacy of Reproterol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The therapeutic efficacy of Octopamine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The therapeutic efficacy of Rimiterol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The therapeutic efficacy of Tretoquinol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The therapeutic efficacy of Prenalterol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The therapeutic efficacy of Xamoterol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14752",
                        "description": "The therapeutic efficacy of Racephedrine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14547",
                        "description": "The therapeutic efficacy of Chloride ion can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Bupranolol may increase the hyperkalemic activities of Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Bupranolol may increase the hyperkalemic activities of Potassium bicarbonate"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Bupranolol may increase the hyperkalemic activities of Potassium acetate"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "Potassium alum may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "Monopotassium phosphate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "Dipotassium phosphate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Sodium phosphate monobasic may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09483",
                        "description": "Potassium lactate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Potassium nitrate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11107",
                        "description": "Potassium bitartrate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11153",
                        "description": "Potassium hydroxide may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13620",
                        "description": "Potassium gluconate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13735",
                        "description": "Potassium guaiacolsulfonate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13831",
                        "description": "Potassium permanganate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13977",
                        "description": "Potassium carbonate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14492",
                        "description": "Potassium triiodide may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Potassium sulfate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "Potassium Iodide may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Potassium perchlorate may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the hyperkalemic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Azelastine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Bupranolol can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Nabiximols"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Trospium"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Reboxetine"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of Bupranolol can be decreased when combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Eletriptan"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Codeine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Chlorzoxazone"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Palonosetron"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Remoxipride"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Meclizine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Phenacetin"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Repinotan"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tafenoquine"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Enclomiphene"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The metabolism of Umeclidinium can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The metabolism of Opium can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The metabolism of Revefenacin can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Bicifadine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The metabolism of Oliceridine can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium acetate"
                    },
                    {
                        "drugbank-id": "DB00326",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium glucoheptonate"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium chloride"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium citrate"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium gluconate"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium Phosphate"
                    },
                    {
                        "drugbank-id": "DB13142",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium glubionate anhydrous"
                    },
                    {
                        "drugbank-id": "DB13231",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium lactate"
                    },
                    {
                        "drugbank-id": "DB13365",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium lactate gluconate"
                    },
                    {
                        "drugbank-id": "DB13590",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium pangamate"
                    },
                    {
                        "drugbank-id": "DB13800",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium levulinate"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium cation"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Bupranolol can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Bupranolol can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Bupranolol can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Bupranolol can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Bupranolol can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Bupranolol can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Bupranolol can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Bupranolol can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Bupranolol can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Bupranolol can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Bupranolol can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Bupranolol can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Bupranolol can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Bupranolol can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Bupranolol can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "The risk or severity of hypotension can be increased when Carbidopa is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "Enflurane may increase the cardiodepressant activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be decreased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of hypotension can be increased when Prazosin is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "Streptokinase may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Ropinirole may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "Morphine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Nitric Oxide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "Tretinoin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "Isosorbide dinitrate may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Thalidomide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "Paclitaxel may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "Levodopa may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01282",
                        "description": "Carbetocin may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "Amyl Nitrite may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04899",
                        "description": "Nesiritide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "Dinutuximab may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09112",
                        "description": "Nitrous acid may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "Pipamperone may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Sacubitril may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of hypotension can be increased when Aripiprazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of adverse effects can be increased when Timolol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of hypotension can be increased when Clonidine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00040",
                        "description": "The therapeutic efficacy of Bupranolol can be decreased when used in combination with Glucagon"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The therapeutic efficacy of Acetohexamide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The therapeutic efficacy of Tolazamide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The therapeutic efficacy of Glyburide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The therapeutic efficacy of Glipizide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The therapeutic efficacy of Gliclazide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The therapeutic efficacy of Tolbutamide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The therapeutic efficacy of Gliquidone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The therapeutic efficacy of Glisoxepide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The therapeutic efficacy of Glibornuride can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The therapeutic efficacy of Carbutamide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The therapeutic efficacy of Metahexamide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The therapeutic efficacy of Pentamidine can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Mifepristone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The therapeutic efficacy of Bromocriptine can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "The therapeutic efficacy of Insulin human can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "The therapeutic efficacy of Insulin pork can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01306",
                        "description": "The therapeutic efficacy of Insulin aspart can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01307",
                        "description": "The therapeutic efficacy of Insulin detemir can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "The therapeutic efficacy of NN344 can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "The therapeutic efficacy of Insulin beef can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "The therapeutic efficacy of Insulin degludec can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "The therapeutic efficacy of Insulin tregopil can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Phenformin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Alogliptin"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The therapeutic efficacy of Troglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "The therapeutic efficacy of Acarbose can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The therapeutic efficacy of Metformin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00491",
                        "description": "The therapeutic efficacy of Miglitol can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The therapeutic efficacy of Repaglinide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The therapeutic efficacy of Pioglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01252",
                        "description": "The therapeutic efficacy of Mitiglinide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The therapeutic efficacy of Sitagliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01276",
                        "description": "The therapeutic efficacy of Exenatide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01277",
                        "description": "The therapeutic efficacy of Mecasermin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "The therapeutic efficacy of Pramlintide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01382",
                        "description": "The therapeutic efficacy of Glymidine can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01700",
                        "description": "The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "The therapeutic efficacy of Buformin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "The therapeutic efficacy of Vildagliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB04878",
                        "description": "The therapeutic efficacy of Voglibose can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB05819",
                        "description": "The therapeutic efficacy of NBI 6024 can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "The therapeutic efficacy of AMG 222 can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "The therapeutic efficacy of Bisegliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The therapeutic efficacy of Saxagliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB06655",
                        "description": "The therapeutic efficacy of Liraglutide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "The therapeutic efficacy of Gosogliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The therapeutic efficacy of Linagliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09022",
                        "description": "The therapeutic efficacy of Benfluorex can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09043",
                        "description": "The therapeutic efficacy of Albiglutide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The therapeutic efficacy of Dulaglutide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The therapeutic efficacy of Netoglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The therapeutic efficacy of Ciglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "The therapeutic efficacy of Lixisenatide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11698",
                        "description": "The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "The therapeutic efficacy of Dutogliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11780",
                        "description": "The therapeutic efficacy of Allicin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11824",
                        "description": "The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11898",
                        "description": "The therapeutic efficacy of 2 4 thiazolidinedione can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "The therapeutic efficacy of Teneligliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "The therapeutic efficacy of Omarigliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "The therapeutic efficacy of Carmegliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "The therapeutic efficacy of Gemigliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "The therapeutic efficacy of Anagliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "The therapeutic efficacy of Evogliptin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12713",
                        "description": "The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The therapeutic efficacy of Balaglitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12935",
                        "description": "The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13446",
                        "description": "The therapeutic efficacy of Guar gum can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB13928",
                        "description": "The therapeutic efficacy of Semaglutide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14027",
                        "description": "The therapeutic efficacy of Taspoglutide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB14035",
                        "description": "The therapeutic efficacy of Englitazone can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB15171",
                        "description": "The therapeutic efficacy of Tirzepatide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB15217",
                        "description": "The therapeutic efficacy of Gastric inhibitory polypeptide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Pitolisant may increase the QTc prolonging activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The excretion of Bupranolol can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Escitalopram can be increased when it is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Bupranolol may increase the hypotensive activities of Quetiapine"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "Lasmiditan may increase the bradycardic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of adverse effects can be increased when Bupranolol is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Cyclopenthiazide can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The therapeutic efficacy of Bupranolol can be increased when used in combination with Indapamide"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The serum concentration of the active metabolites of Bupranolol can be increased when Bupranolol is used in combination with Octreotide"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypertension can be increased when Bupranolol is combined with Oxymetazoline"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}